European Regulator Confirms Milestone Medical-Data Transparency Data

October 8, 2014

(Nature) – Clinical trial data previously kept behind closed doors is to be released to the public by Europe’s medical regulator, after a new transparency policy was finally agreed at the European Medicines Agency (EMA). The EMA, which is responsible for licencing drugs to be sold in European Union states, has been embroiled in a long-running debate about how it could or should release information submitted by drugs companies seeking permission to market their medicines.